Morin and Esculetin supplementation modulates c-myc induced energy metabolism and attenuates neoplastic changes in rats challenged with the procarcinogen 1,2 - dimethylhydrazine
Morin and esculetin possess significant anti-colon cancer activity. Morin and esculetin down regulate glycolysis and glutaminolysis in colon cancer. Morin and esculetin targets β-catenin driven c-myc mediated energy metabolism. Morin exerts more pronounced effect than esculetin and morin plus esculetin.